Type and hit ENTER

Announcements

All the posts published.

ProAxsis will today be presenting new data on its highly novel active neutrophil elastase (NE) point-of-care test, NEATstik®, at the European …

September 18, 2018

ProAxsis Limited has been declared as the “Innovative Business of the Year” at the Business Eye First Trust Awards (BEFTAs) for …

June 4, 2018

ProAxsis Limited has received an Invest NI Grant for Research and Development, supporting the company to develop new products using its innovative …

June 1, 2018

ProAxsis Limited has contracted with National Jewish Health (NJH), the leading respiratory hospital in the United States, to validate the company’s …

October 27, 2017

ProAxsis was delighted to see its ProteaseTag® technology incorporated in to an important study presented at the European Cystic Fibrosis Society …

June 19, 2017

ProAxsis Ltd is delighted to observe that its ProteaseTag® Active Neutrophil Elastase Immunoassay is prominently featured in the most recent edition of …

May 17, 2017

ProAxsis Limited (www.proaxsis.com) is delighted to announce that it has secured a second licensing agreement with the Queen’s University of Belfast for …

May 10, 2017

ProAxsis is delighted to announce that Dr Kelly Moffitt has joined the company in the role of Senior Project Manager, and will …

May 9, 2016

ProAxsis CEO David Ribeiro was interviewed by ProActive Investors UK. Watch the video on Stock-Tube

May 4, 2016

ProAxsis is pleased to announce the appointment of Sarah Ganniclefft to the newly created role of Sales and Marketing Manager. Sarah …

April 20, 2016
Announcements Archives | ProAxsis